Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone density in Type 1 Gaucher disease

G M Pastores1, S Wallenstein, R J Desnick

  • 1Department of Human Genetics, Mount Sinai School of Medicine, New York, New York, USA.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erythropoietic protoporphyria: time to prodrome, the warning signal to exit sun exposure without pain-a patient-reported outcome efficacy measure.

Genetics in medicine : official journal of the American College of Medical Genetics·2021
Same author

A bolt from the blue; A case report of an unusual asthma exacerbation.

Respiratory medicine case reports·2020
Same author

Harderoporphyria: Case of lifelong photosensitivity associated with compound heterozygous coproporphyrinogen oxidase (CPOX) mutations.

Molecular genetics and metabolism reports·2019
Same author

Autosomal Dominant Gene Negative Frontotemporal Dementia-Think of SCA17.

Cerebellum (London, England)·2019
Same author

Many pitfalls in diagnosis of acute intermittent porphyria: a case report.

BMC research notes·2018
Same author

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.

Blood cells, molecules & diseases·2017
Same journal

Ossification of the Posterior Longitudinal Ligament - Novel findings from Pandora's box of ENPP1 Deficiency.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same journal

From loci to cells: mapping variant function in bone and joint diseases.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same journal

The Journal of Bone and Mineral Research (JBMR) 40th anniversary celebration: the fourth decade (Part 2).

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same journal

Increased Prevalence of Coronary Artery Calcification in Patients with Post-Surgical Hypoparathyroidism.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same journal

Alendronate for 6 or 12 months following denosumab discontinuation in women with postmenopausal osteoporosis: A prospective observational study.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same journal

Is Zoledronic acid cost-saving in daily practice?

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
See all related articles

Bone density is significantly reduced in Type 1 Gaucher disease patients. Bone densitometry offers a valuable, noninvasive method for assessing and monitoring skeletal complications in this progressive genetic disorder.

Area of Science:

  • Medical Genetics
  • Bone Metabolism
  • Rare Diseases

Background:

  • Skeletal complications are a primary concern for individuals with Type 1 Gaucher disease.
  • Assessing bone health is crucial for managing Gaucher disease patients.

Purpose of the Study:

  • To evaluate bone density in adult patients with Type 1 Gaucher disease.
  • To determine the utility of bone densitometry for assessing skeletal involvement.

Main Methods:

  • Dual-energy X-ray absorptiometry (DXA) was employed to measure bone mineral density.
  • Measurements were taken at the lumbar spine, femoral neck, trochanter, and distal radius in 61 adult patients.
  • Bone density was correlated with clinical indicators and radiographic skeletal assessments.

Related Experiment Videos

Main Results:

  • Patients with Type 1 Gaucher disease exhibited significantly lower bone density across all measured sites compared to age- and sex-matched controls.
  • Osteopenia severity correlated with disease severity markers like N370S/84GG genotype, splenectomy history, and hepatomegaly.
  • Vertebral bone density independently predicted the extent of skeletal involvement.

Conclusions:

  • Bone densitometry provides a quantitative measure of skeletal involvement in Type 1 Gaucher disease.
  • DXA measurements can serve as a noninvasive tool for serial monitoring of bone changes.
  • This approach aids in managing the progressive skeletal manifestations of Gaucher disease.